TITLE

Economic Issues: Toward a Cost-Effective Approach to the Management of Febrile Neutropenia in Japan

AUTHOR(S)
Masaoka, Tohru
PUB. DATE
July 2004
SOURCE
Clinical Infectious Diseases;7/1/2004 Supplement 1, Vol. 39, pS68
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The cost of treating neutropenic patients unexplained fever is of significant concern in Japan because of the depressed economy and the aging population. Development of a standardized treatment methodology specifically tailored to the situation in Japan will make the treatment more efficient for health care institutions, will allow for improved monitoring of practices and costs, and will result in better patient care. It is essential, however, that the welfare of the patients be the utmost priority--cost savings is not sufficient in the absence of a significant impact on morbidity and mortality.
ACCESSION #
13723722

 

Related Articles

  • Outpatient treatment of febrile neutropenia is viable.  // PharmacoEconomics & Outcomes News;2/23/2008, Issue 547, p5 

    The article discusses research being done on outcomes and cost of outpatient or inpatient management of patients with febrile neutropenia. It references a study by L. S. Elting, published in the February 1, 2008 issue of the "Journal of Clinical Oncology." Researchers contend that outpatient...

  • Upcoming Infectious Disease Activities.  // Emerging Infectious Diseases;Jan2005, Vol. 11 Issue 1, p190 

    Presents the schedule of conferences concerning infectious disease, as of January 2005. 7th International Symposium on Febrile Neutropenia which will be held at Barcelo Gran Hotel Renacimiento in Seville Spain on January 27-29; Focus on Fungal Infections to be held at Sheraton Bal Harbour in...

  • Management of Febrile Neutropenia: Current Strategies. Bodey, Gerald; Rolston, Kenneth V. I.; Sepkowitz, Kent; Viscoli, Claudio // Clinical Infectious Diseases;4/1/2005 Supplement, Vol. 40, pS257 

    The article presents a post-test related to febrile neutropenia that appeared in the 2005 issue of the journal "Clinical Infectious Diseases." Some of the questions were about the condition when a patient with febrile neutropenia may not be an appropriate candidate for outpatient treatment,...

  • Treating febrile neutropenia. Birchfield, Mary E.B.; Vozniak, J. Michael // Drug Topics;5/17/2004, Vol. 148 Issue 10, pHSE6 

    Two physicians gave their recommendations for the treatment of febrile neutropenia on a 42-year-old man who was diagnosed with non-Hodgkin's lymphoma. Since his diagnosis, he has been treated with various chemotherapy regimens including cyclophosphamide/doxorubicin/ vincristine/ prednisone, and...

  • Economic Issues: Toward a Cost-Effective Approach to the Management of Febrile Neutropenia in Japan. Masaoka, Tohru // Clinical Infectious Diseases;7/15/2004 Supplement 1, Vol. 39, pS68 

    The cost of treating neutropenic patients unexplained fever is of significant concern in Japan because of the depressed economy and the aging population. Development of a standardized treatment methodology specifically tailored to the situation in Japan will make the treatment more efficient for...

  • Multicentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL Study. Jurczak, Wojciech; Kalinka-Warzocha, Ewa; Chmielowska, Ewa; Duchnowska, Renata; Wojciechowska-Lampka, Elzbieta; Wieruszewska, Karolina // Contemporary Oncology / Wspolczesna Onkologia;2015, Vol. 19 Issue 3, p214 

    Aim of the study: PROFIL was a prospective observational study conducted to investigate physicians' evaluation of febrile neutropenia (FN) risk and reasons for giving pegfilgrastim primary prophylaxis (PP) in routine clinical practice in Poland. Material and methods: Adult cancer patients...

  • How long to wait for culture results?  // Archives of Disease in Childhood;Oct2014, Vol. 99 Issue 10, p906 

    The article offers information on a study to determine the causes of sudden fever in infants. Topics discussed include use of automated technology for the early detection of blood cultures, introduction of a vaccine against Group B Streptococcus (GBS) for pregnant women to obtain future positive...

  • Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998–2002. Tuboi, Suely Hiromi; Costa, Zouraide Guerra Antunes; da Costa Vasconcelos, Pedro Fernando; Hatch, Douglas // Transactions of the Royal Society of Tropical Medicine & Hygiene;Feb2007, Vol. 101 Issue 2, p169 

    Summary: Yellow fever (YF), an arboviral infection of major public health importance in Brazil, is associated with high mortality and high epidemic potential. We analysed confirmed YF cases from the National Surveillance System from 1998–2002 and assessed risk factors for death among...

  • Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998–2002. Tuboi, Suely Hiromi; Costa, Zouraide Guerra Antunes; da Costa Vasconcelos, Pedro Fernando; Hatch, Douglas // Transactions of the Royal Society of Tropical Medicine & Hygiene;Feb2007, Vol. 101 Issue 2, p169 

    Summary: Yellow fever (YF), an arboviral infection of major public health importance in Brazil, is associated with high mortality and high epidemic potential. We analysed confirmed YF cases from the National Surveillance System from 1998–2002 and assessed risk factors for death among...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics